Unlock stock picks and a broker-level newsfeed that powers Wall Street.
2.3460
-0.2240
(-8.72%)
At close: April 4 at 9:33:54 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 2 | 6 | 6 |
| Avg. Estimate | 20.58M | 13.56M | 524.17M | 73.75M |
| Low Estimate | -- | -- | 493.11M | -- |
| High Estimate | 76.91M | 27.11M | 543.1M | 154.78M |
| Year Ago Sales | 22.6M | 12.37M | 53.8M | 524.17M |
| Sales Growth (year/est) | -8.93% | 9.57% | 874.29% | -85.93% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 5CV.F | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/14/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/16/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/16/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/3/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/25/2024 |
| Reiterates | Guggenheim: Neutral | 4/5/2024 |
Related Tickers
0QF.F Moderna, Inc.
23.01
-6.22%
PHGN.BE Pharming Group
0.7150
-2.26%
RGO.SG Regeneron Pharmaceuticals Inc
524.00
-5.59%
MDG1.F Medigene AG
0.6680
+4.37%
FYB.F Formycon AG
22.35
-0.45%
MEDCL.PA MedinCell S.A.
13.38
-3.88%
22UA.F BioNTech SE
81.45
-1.27%
FYB.DE Formycon AG
22.90
+0.44%
ABVX.PA ABIVAX Société Anonyme
5.0000
-7.24%
MDG1.DE Medigene AG
0.6600
-6.25%